Biolife Solutions (BLFS) Change in Accured Expenses (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Change in Accured Expenses of $26000.0 for Q1 2026, up 62.5% year-over-year from $16000.0 in Q1 2025, and down 96.18% quarter-over-quarter from $680000.0 in Q4 2025.
Biolife Solutions (BLFS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Change in Accured Expenses for 17 consecutive years, with $26000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 62.5% year-over-year to $26000.0; the TTM figure through Mar 2026 stood at -$1.1 million (down 112.16% YoY), while the FY2025 annual figure was -$1.1 million, down 117.64% from the prior year.
- Change in Accured Expenses declined to $26000.0 in Q1 2026 per BLFS's latest filing, from $680000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $7.1 million in Q4 2024 and bottomed at -$2.8 million in Q1 2024.
- Historically, Change in Accured Expenses has averaged $610400.0 across 5 years, with a median of $43000.0 in 2023.
- On a YoY basis, Change in Accured Expenses climbed as much as 4516.28% in 2024 and fell as far as 14025.0% in 2024.
- Biolife Solutions' Change in Accured Expenses stood at $1.3 million in 2022, then soared by 175.06% to $3.7 million in 2023, then soared by 91.09% to $7.1 million in 2024, then slumped by 90.37% to $680000.0 in 2025, then sank by 96.18% to $26000.0 in 2026.
- Business Quant data shows BLFS's Change in Accured Expenses at $26000.0 in Q1 2026, $680000.0 in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 55.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 50.56 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 29.00 Mn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | -755,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -755,000.00 |
| Jun 30, 2026 | -755,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 680,000.00 |
| Dec 31, 2025 | 680,000.00 |
| Sep 30, 2025 | -1.82 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -16,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 7.06 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | 266,000.00 |
| Sep 30, 2024 | 266,000.00 |
| Jun 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Mar 31, 2024 | -2.83 Mn |